Contineum Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Contineum Therapeutics Inc had 14.71M in cash and cash equivalents.

Contineum Therapeutics Inc reported 15.65M in total liabilities as of the latest reported quarter, including 9.74M in current liabilities and 5.91M in non-current liabilities.

As of the latest reported quarter, Contineum Therapeutics Inc's total assets were 276.64M, consisting of 267.92M in current assets and 8.72M in non-current assets.

Contineum Therapeutics Inc reported 260.99M in total shareholders' equity as of the latest reported quarter.